Skip to main content

Market Overview

Why iBio, Sutro And Cantel Medical Are Moving Today

Share:
Why iBio, Sutro And Cantel Medical Are Moving Today

iBio (NYSE: IBIO) shares are trading lower on Tuesday after the company announced a common stock offering.

iBio’s main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates.

iBio shares were trading down 15% at $1.28 during the time of publication. The stock has a 52-week high of $7.45 and a 52-week low of 19 cents.

Sutro Biopharma (NASDAQ: STRO) shares are trading lower after the company announced a 5 million share common stock offering.

Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. Its focus is aimed primarily on next generation cancer and autoimmune therapeutics — antibody conjugates, bispecific antibodies and cytokine derivatives.

Sutro Biopharma shares were trading down 9.41% at $19.84. The stock has a 52-week high of $25.49 and a 52-week low of $6.

Cantel Medical (NYSE: CMD) shares are trading higher after the company reported better-than-expected first-quarter EPS and sales results.

Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies.

Cantel Medical shares were trading up 22.34% at $75.36. The stock has a 52-week high of $79.50 and a 52-week low of $20.81.

 

Related Articles (CMD + IBIO)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Small Cap Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com